US drugmaker Eli Lilly and Company will invest more than $1 billion in India over the next few years, as it looks to expand manufacturing and strengthen supply chains for some of its key medicines.

The company will work with local contract manufacturers and set up a new Manufacturing and Quality hub in Hyderabad to overs

📰

Continue Reading on India Today

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →